Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target Immune System Health Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target admin January 2, 2026 0 Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A. &... Read More Read more about Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation Kidney Health Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation admin November 4, 2025 0 The study adhered to the ethical principles of the Declaration of Helsinki33 and followed the Strengthening... Read More Read more about Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation
Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation Kidney Health Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation admin November 4, 2025 0 The study adhered to the ethical principles of the Declaration of Helsinki33 and followed the Strengthening... Read More Read more about Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation
